Metformin to Limit Abdominal Aortic Aneurysm Expansion: Time for Clinical Trials
- PMID: 33836975
- DOI: 10.1016/j.ejvs.2021.02.056
Metformin to Limit Abdominal Aortic Aneurysm Expansion: Time for Clinical Trials
Comment on
-
The Metformin for Abdominal Aortic Aneurysm Growth Inhibition (MAAAGI) Trial.Eur J Vasc Endovasc Surg. 2021 Apr;61(4):710-711. doi: 10.1016/j.ejvs.2020.11.048. Epub 2021 Jan 27. Eur J Vasc Endovasc Surg. 2021. PMID: 33516615 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
